| |
|
|
|
The Center for Professional Advancement, An Online Training Format
February 21, 2008
Who Should Attend
Representatives of small to medium sized businesses in the vaccine, biotech, pharmaceutical and device industries interested in learning how to apply for Biodefense Grant Funding. The course will be especially beneficial to the following professionals: - Scientists
- Clinical
- Financial
- Operations
- R&D
- Research organizations (including Universities and Laboratories)
- Managers
Description
The United States government is currently distributing over $5 billion in biodefense grants and contracts: private foundations and international organizations have expanded the pool of funds. This 90-minute online course is designed to provide the tools to allow a small to medium sized biotechnology, pharmaceutical or medical device company apply for a portion of that pool to support research, product development and/or operations. Suggestions for finding and evaluating opportunities and for developing a compelling application are provided.
Module 1: Scope of Funding and Finding Opportunities- The scope of biodefense funding
–Pandemics: avian influenza, SARS, etc.
–Bio protection for military troops and home front
–Detection equipment
–Protective equipment
–Preventatives
–Therapies - Finding biodefense grant opportunities
–Government: grants.com
–Private
–International
Module 2: The Application Process - The Grant Application process
–Pre-Meeting
–Application
–Qualification
–Budgeting
–Description
–Compelling testimonial - Political process
Module 3: Award Criteria and Summary - Grant award criteria
–Success potential
–Cost/benefit
–Pressing need
- Summary
|
|
|
|
|
|
|
|
Organized by:
|
|
The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
Dr. Sandy Weinberg; Vice President, Regulatory and Quality Assurance, Tikvah Therapeutics, Inc.
Dr. Sandy Weinberg VP, Regulatory, TIKVAH Therapeutics, is former Sr. Director, Fast Trak Vaccines, GE Healthcare and has been the leader in the field of system validation for more than twenty years. He has consulted to the FDA, most other regulatory agencies worldwide, and the industry on techniques for assuring data quality and control since first identifying significant data problems in 1976. Dr. Weinberg is the author of numerous system validation books and articles, including The GALP Regulatory Handbook, The Handbook of System Validation, and System Validation Annual.His most recent articles include “Cost Effective Validation for LIMS” and “Conforming to Part 11 Regulations”.
Dr. Weinberg served as a professor of biomedical informatics at Muhlenberg College in Allentown, Pennsylvania, USA. He is also a member of the board of the KEMA Registered Quality (ISO 9000 Certifier) in the United States and the Netherlands, and an investor in and board member of several international biomedical companies.
Working as a consultant, Dr. Weinberg provides auditing and advisory services in regulatory areas related to system validation. Recent projects include the auditing and certification of a chromotography control system; auditing and advisory services related to a pharmaceutical inventory system; and validation of a Laboratory Information Management System (LIMS). Much of Dr. Weinberg’s practice is centered in Western Europe and Israel.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
info@cfpa.com
|
|
|
|
|
|
|
|
|